incomeacquisition.com
OncoSec Medical Incorporated Penny Stocks (ONCS) - IncomeAcquisition.com
http://incomeacquisition.com/oncosec-medical-incorporated-penny-stocks-oncs
Investing in Stocks, Commodities and Real Estate. OncoSec Medical Incorporated Penny Stocks (ONCS). OncoSec Medical Incorporated Penny Stocks (ONCS). August 18, 2014. Middot; by admin. Middot; in Uncategorized. 9810 Summers Ridge Road. San Diego, CA 92121. Website: http:/ www.oncosec.com. As always penny stocks and penny stock investing is very risky an you should assume you are going to loose your entire investment before ever investing in a penny stock. Leave a Reply Click here to cancel reply.
breakaway-training.com
Sponsors Archive - Breakaway Training
http://breakaway-training.com/sponsors
Multisport Coaching and Personal Training. Nytro Men’s Team. Nytro Men’s Team. Http:/ www.oncosec.com. Cutting edge biotech company developing treatments for advanced-stage skin cancer. Guiseppe Restaurants and Fine Catering. Http:/ www.giuseppecatering.com/. Offers the finest restaurant and event catering in Southern California. Http:/ www.lajollaifv.com. World renowned fertility specialists. Http:/ www.nytro.com. The triathlon supplier and choice of champions since 1992. Http:/ www.oofos.com/.
bioelectricsworkshop.com
Bioelectrics Workshop
http://www.bioelectricsworkshop.com/Sponsors.html
This is event is sponsored by:. 4211 Monarch Way, Ste. #300, Norfolk, VA-23508.
kharecom.com
OncoSec — Kharé Communications
http://www.kharecom.com/oncosec-1
Kharé Communications has proudly created media content for OncoSec, a leader in developing biotechnology and engineering in the fight against cancer. We have been privileged enough to be able to not only create their promotional content, but also to document their journey over these past several years. Our videos provide a clean and concise view onto the numerous technologies on display. Over the course of a normal production day, our team captures the OncoSec team at work in their own environment - ...
isdv.org
Sponsor Tiers :: International Society of DNA Vaccines
http://www.isdv.org/2014/sponsors
Navigate International Society of DNA Vaccines. Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases. Its SynCon vaccines provide universal cross-strain protection against divergent unmatched strains of pathogens. In combination with Inovio's proprietary electroporation delivery, they have in humans generated best-in-class immune responses with a favorable safety profile. http:/ www.inovio.com. Aldevron is a world-class service organization specializ...
ngtcancervaccines.com
CVGT 2013 Agenda
http://www.ngtcancervaccines.com/Agenda_2013_old.html
Agenda from the 1st Annual CVGT Meeting. Which took place 3 - 4 October 2013. Day 1, 03-October 2013. Ingmar Hoerr, CEO of CureVac. Messenger RNA, a Disruptive Technology. Jeffrey Ulmer, Global Head, External Research at Novartis. Technologies for New and Improved Vaccines. Iver Arne Langmoen, Professor, University of Oslo, Norway. Vaccination against autologous cancer stem cells in patients with brain cancer. BREAK / COFFEE and FOOD. Frank Bedu-Addo, President and CEO of PDS Biotechnology. Luigi Aurisic...
ir.oncosec.com
Quarterly Reports
http://ir.oncosec.com/quarterly-reports
Media & Events. Quarterly report pursuant to Section 13 or 15(d). Quarterly report pursuant to Section 13 or 15(d). Quarterly report pursuant to Section 13 or 15(d). Quarterly report pursuant to Section 13 or 15(d). Quarterly report pursuant to Section 13 or 15(d). Quarterly report pursuant to Section 13 or 15(d). Quarterly report pursuant to Section 13 or 15(d). Quarterly report pursuant to sections 13 or 15(d). Quarterly report pursuant to sections 13 or 15(d).
ir.oncosec.com
Overview
http://ir.oncosec.com/overview
Media & Events. Advancing a lead portfolio of gene therapies for cancer. Platform focused on reversing tumor immune suppression. Phase II clinical programs focused on addressing unmet need of T-cell poor tumors. Clinical data demonstrates proof of concept of the technology. Rapid preclinical development platform. OncoSec Announces Peer-Reviewed Publication of T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Therapy in Melanoma. Aug 15, 2016. Apr 30, 2016. Sign up for email alerts.
ngtcancervaccines.com
CVGT 2014 Agenda
http://www.ngtcancervaccines.com/Agenda_2014_old.html
Agenda from the 2nd Annual CVGT Meeting. Which took place 6 - 7 October 2014. Day 1, MONDAY, 06 OCTOBER 2014. REGISTRATION & BREAKFAST (3rd Floor Artium). Mariola Fotin-Mleczek, Chief Scientific Officer at CureVac. RNActive technology platform for potent cancer vaccines. BREAK / COFFEE and FOOD (3rd Floor Breakroom). Leisha Emens, Associate Professor of Oncology, Johns Hopkins University School of Medicine. Anti-Angiogenic Therapy and Tumor Vaccines: Convergence on the T Cell. CARs for leukemia and beyond.
SOCIAL ENGAGEMENT